The second brand in the world health organization test list
Colloidal Gold Method
This kit applies the principle lateral flow chromatographic immunoassay and uses capture method to detect specific IgM and IgG antibodies against novel coronavirus in human
specimens (serum, plasma and venous whole blood).
The Diagnostic Kit for SARS-CoV-2 IgM/IgG Antibody (Colloidal Gold) adopts the solid phase colloidal gold immunochromatographic technology for the qualitative determination of IgM/IgG antibodies against SARS-CoV-2
SARS-CoV-2 IgG/IgM Cartridge
Kit include : 1 Test Box + 1 Cartridge + 1 UV Touch
SARS-CoV-2 IgG/IgM Kit is used for rapid and accurate screening of the COVID-19, which helps identify suspected patients and
reduce false negative rate. Rapid detection of recent SARS-CoV-2 infection
In ONLY 12 minutes
ONE-STEP operation
Single cartridge, NO additional buffers
TRFIA Europium particles displays Clear and Bright results
Dual capturing antigens (S and N) enhanced sensitivity
Important complement to PCR detection in COVID-19 diagnosis
Product Name : COVID-19 SARS-CoV-2 IgM Antibody Test Kit
Product Description :
Material attachment is good. The shell of the detection card should be flat, the upper and lower covers should be closed evenly, and there should be no obviousgap.Thediluentshouldbeclearandfree offoreignmatter. 1.6 Size:thesizeofteststripshouldnotbelessthan2.5mm. 1.7 Liquidmigrationspeedshouldnotbelessthan10mm/min. 2.Minimumdetectionlimit TheminimumtestlimitreferenceproductsS1shouldbenegative,S2andS3shouldbepositive. 3.Negativecompliancerate 5copiesofnegativereferenceproductsof thetestcompanyshallbeallnegative,withanegativecompliancerateof100%. 4.Positivecompliancerate
5copiesofnegativereferenceproductsof thetestcompanyshallbeallpositive,withanegativecompliancerateof 100%. 5.Repeatability Test1copyoftheenterprisepositivereference,test10times,shouldbeconsistentcolor,arepositive. 6.Specificity 6.4 Cross Reaction: This product with vice influenza virus antibodies, influenza a virus, influenza b virus antibodies, pneumonia chlamydia, mycoplasma pneumoniae antibody, adenovirus antibody, respiratory syncytial virus antibody, hepatitisbsurfaceantibody,hepatitis cvirusantibody,treponemapallidumantibody,humanimmunodeficiencyvirus(HIV) antibodies,EBvirusantibody,measlesvirus,CMVantibodies,enterovirustype71,mumpsvirusantibody,varicella - zoster viruspositivesamples nocrossreaction. 6.5 Thereisnocross-reactionbetweenRF,ANAandAMA. 6.6 Interferingsubstance: (3) When bilirubin concentration =250 mol/L, hemoglobin content =9g/L, triglyceride content =15mmol/L,content of rheumatoid factor =80IU/mL, titer ofANA=1:240, anti-mitochondrial antibody (AMA) =80U/mL, content of mouse IgG=1000g/mL,therewillbenointerferencewiththetestresultsof thisproduct. (4) The commonly used antiviral drugs epiztin acid (=4mg/L), ribavirin (=40mg/L), interferon (=200mg/L), oseltamivir (=30mg/L), abidol (=40mg/L), levofloxacin (=200mg/L), azithromycin (=100mg/L), ceftriaxone (=400mg/L), meropenan(=200mg/L) havenointerferenceinthedetectionofthisproduct. 7. Hookeffect No hook effect was found in the test results of this product within the titer range of clinically positive samples of the novel coronavirusantibody.
Price of product ( USD price or FOB price) : $4.23
Product origin : China
Key Specifications/Special Features :
CE
FDA
Hospital professional testing and use, family and individuals can not use
Minimum Order Size and Packgaing details:
MOQ:10000pieces
25pieces/box box size:15*14*6.5cm ,150g/box
100boxes /CTN,CTN Size 72*62*36cm 21KG(without lancet and alcohol cotton)
Supplier: Ethanol /alcohol process line/machine,ethanol/alcohol turnkey project , industry fruit process machine/production line ,industry vegetable process machine/production line, industry noodle machine/production line , industry bread/cake machine/process line and so on . industry waste water treatment system process line .packing machine Services: Our company's products, technical support, training, installation and commissioning
SARS-CoV-19 IgG/IgM test kit (15min showing result)
Manufacturer: Guangzhou Wanfo Biotech Co., Ltd. a China listing company
Certificates: CE certificate, China NMPA approval (export allowed), no FDA approval
The price is $5.5/test (FOB)
Max delivered quantity: 100,000/weekly
More details please enquire Barry Liu whatsapp: +8617810331113
sample available: 20 test & DHL delivery: $200
Download introductions: https://kdocs.cn/l/sLLC9O6rc
Cat. No : 5513C. COVID-19 serology test.Cellex qSARS-CoV-2 IgG/IgM Rapid Test.qSARS-CoV-2 IgG/IgM Rapid Test Cassette.FDA Grants Emergency Authorization for First Rapid Antibody Test for COVID-19
INTENDED USE
For qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, sodium citrate and lithium heparin) or fingerstick whole blood, venous whole blood specimens from patients suspected of COVID-19 infection.
FEATURES
Coated with carefully selected specific Nucleocapsid and Spike protein antigen.
Detection for IgM and IgG antibodies simultaneously.
Simple operation, easy result interpreted.
Rapid test within 15 minutes.
RESULTS INTERPRETATION
Positive:
1. The presence of 3 red lines (T1, T2 and C) within the reaction window, no matter which band appears first, indicates presence of both SARS-CoV-2 IgM and IgG antibodies.
2. The presence of 2 red lines (T1 and C) within the reaction window, no matter which band appears first, indicates presence of SARS-CoV-2 IgM antibody.
3. The presence of 2 red lines (T2 and C) within the reaction window, no matter which band appears first, indicates presence of SARS-CoV-2 IgG antibody.
Negative:
1. The presence of line (control line) only within the reaction window indicates that no SARS-CoV-2 antibodies are detected. The results is negative.
Invalid:
1. If the control(C) line is not displayed in 10-15 min, regardless of whether T1 and/or T2 line is present, the test result is invalid. It is recommended that the specimen should be re-tested.
2. The test result is invalid after 15 min.
This kit is used to qualitatively detect the novel coronaviruses (SARS-CoV-2) antigen in human nasal throat swabs, oral throat swabs, posterior oropharyngeal saliva, sputum and stool samples.
